Abstract:The cell-mediated immune response involves a series of specific molecular interactions between cell surface molecules on T cells and antigen-presenting cells. Of particular importance for the regulation of T cell activity is the interaction of the B7 isoforms, B7-1 and B7-2, with the T cell surface costimulatory receptors, CD28 and CTLA-4. The binding of CD28 by B7-1/B7-2 results in an enhancement of T cell responses initiated by the interaction between a clonotypic T cell receptor and its specific, antigenic MHC-peptide complex, whereas the subsequent engagement of CTLA-4 by B7-1/B7-2 leads to a down-regulation of the response. Here we report the expression, refolding, purification, characterization, and crystallization of the receptor-binding domain of human B7-2. The receptor-binding domain of human B7-2 was overexpressed in Escherichia coli as inclusion bodies, solubilized in 6 M guanidine-hydrochloride, and then refolded in vitro by rapid dilution into a renaturing buffer. Refolded B7-2 was subsequently purified to homogeneity by anion-exchange chromatography. Gel-filtration chromatography and native PAGE analysis showed that the receptor-binding domain of B7-2 is exclusively monomeric in solution. Purified B7-2 binds tightly to bacterially expressed monomeric and disulfide-linked homodimeric human CTLA-4 as shown by gel-filtration chromatography and native PAGE. This suggests that glycosylation is not important for the proper folding of the receptor-binding domain of B7-2 nor for its binding to CTLA-4. In addition, these results suggest that refolded B7-2 is biologically active and may be a useful therapeutic and experimental reagent for regulating T cell activity. Refolded and purified B7-2 was crystallized by the hanging-drop vapor diffusion method, allowing for the initiation of an X-ray crystallographic study.

Expression, Refolding, Purification, Molecular Characterization, Crystallization, and Preliminary X-ray Analysis of the Receptor Binding Domain of Human B7-2

Crystal Structure of the Receptor-Binding Domain of Human B7-2: Insights into Organization and Signaling

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

Bacterially Produced Human B7-1 Protein Encompassing Its Complete Extracellular Domain Maintains Its Costimulatory Activity in Vitro.

Recombinant Human B7.2 Igv-Iike Domain Expressed In Bacteria Maintains Its Co-Stimulatory Activity In Vitro

Preparation of Functional Monoclonal Antibody Against Human B7-2 Molecule and Analysis of Its Biological Characteries

Expression, crystallization and X‐ray diffraction analysis of a complex between B7‐H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody

Prokaryotic High-Level Expression and Activity Assay of Extracellular Domain of B7-2 (CD86) in Vitro

The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.

Eukaryotic expression of B7.1 extracellular domain and its biological activities

Recombinant human B7-H4 expressed in Escherichia coli inhibits T lymphocyte proliferation and IL-2 secretion in vitro

[Expression and identification of recombinant mouse gene B7-H4].

[The Identical Effects of B7-1 and B7-2 on Regulation of Human IL-2 Gene Transcription Factors NF-kappa B and AP-1].

Eukaryotic Expression of Recombinant B7-H3Ig Protein and Its Effects on T Cells

Human Recombinant B7-H3 Expressed in E. Coli Enhances T Lymphocyte Proliferation and IL-10 Secretion in Vitro.

Cloning, Purification and Bioactivity Assay of Human CD28 Single-Chain Antibody in Escherichia Coli

Complex Assembly, Crystallization and Preliminary X-ray Crystallographic Analysis of the Chicken CD8αα-BF2*0401 Complex.

Structure and Cancer Immunotherapy of the B7 Family Member B7x.

IN VITRO CO-STIMULATORY ACTIVITY OF HUMAN B7.2(IgV+C) PROTEIN PRODUCED BY ENGINEERED BACTERIA

Preparation of a Monoclonal Antibody Against Human 41Gb7-H3 Molecule and Analysis of Its Biological Characteristics

Expression, Purification, and Crystallization of the Vγ9Vδ2 T-cell Receptor Recognizing Protein/Peptide Antigens